Page 136 - IJB-7-1

Actualizing Hybrid Pressure and Silicone Therapies with 3D Printing and Scanning
silicone sheet and scar treating gel is not recommended References
for treatment of HSs. Instead, we propose a novel
bespoke HS treatment involving a combination of 3D 1. Ogawa R, 2020, Total Scar Management : From Lasers to
scanning, 3D printing, FEA, computer-aided design, Surgery for Scars, Keloids, and Scar Contractures. Springer,
and manufacturing software. The 3D printed silicone Singapore.
elastomer that only covers the HS itself is secured to https://doi.org/10.1007/978-981-32-9791-3
a bespoke pressure sleeve. Since the silicone sheet is 2. Tredget EE, Nedelec B, Scott PG, et al., 1997, Hypertrophic
secured by the pressure from the sleeve, any type of scar Scars, Keloids, and Contractures: The Cellular and Molecular
treating gel can be applied at the same time. Using an Basis for Therapy. Surg Clin North Am, 77(3):701–30.
FEA, the pressure dosage for the HS can be accurately
modified, which in this case, is approximately 25 mmHg https://doi.org/10.1016/s0039-6109(05)70576-4
for the effective management of HS. Most importantly, 3. Grose R, Werner S, 2004, Wound-healing Studies in
the unnecessary pressure exerted on normal skin can be Transgenic and Knockout Mice. Appl Biochem Biotechnol
reduced by approximately 60%, 56%, and 80% at the Part B Mol Biotechnol, 28(2):147–66.
ulnar, radial, and back of the hand, respectively. In this https://doi.org/10.1385/mb:28:2:147
case study, the suggested treatment provides a significant 4. Son D, Harijan A, 2014, Overview of Surgical Scar Prevention
effect in reducing the scar thickness and pigmentation. and Management. J Korean Med Sci, 29(6):751–7.
Also, there is no adverse effects of the hybrid pressure
and silicone therapy found. The developed design https://doi.org/10.3346/jkms.2014.29.6.751
framework and production of the pressure garment can 5. Enoch S, Leaper DJ, 2008, Basic Science of Wound Healing.
contribute to new insights for future HS therapies and Surgery (Oxford), 26(2):31–7.
new customized clinical products for scars. https://doi.org/10.1016/j.mpsur.2007.11.005
6. Werner S, Krieg T, Smola H, 2007, Keratinocyte-fibroblast
Acknowledgments
Interactions in Wound Healing. J Investig Dermatol,
We acknowledge the financial support of the Research 127(5):998–1008.
Grant Council for funding this research project (project https://doi.org/10.1038/sj.jid.5700786
account PolyU 152097/18E). 7. Nagase H, Woessner JF, 1999, Matrix Metalloproteinases.
Conflicts of interest J Biol Chem, 274(31):21491–4.
https://doi.org/10.1074/jbc.274.31.21491
The authors report no potential conflicts of interest.
8. Bock O, Schmid-Ott G, Malewski P, et al., 2006, Quality of
Author contribution Life of Patients with Keloid and Hypertrophic Scarring. Arch
Dermatol Res, 297(10):433–8.
L.C. designed the workflow, methodology, data curation https://doi.org/10.1007/s00403-006-0651-7
and prepared the original draft of the manuscript and
figures. Co-authors Y.S., M.S.H.L and M.Y.K involved 9. Mazharinia N, Aghaei S, Shayan Z, 2007, Dermatology life
in the investigation and analysis of results. K.L.Y. quality index (DLQI) scores in burn victims after revival.
supervised and administered the project. K.L.Y., S.P.N, J Burn Care Res, 28(2):312–7.
A.Y., J.Y. and Y.F.C. acquired the project funding, and https://doi.org/10.1097/bcr.0b013e318031a151
reviewed and edited the manuscript. 10. Kwan P, Hori K, Ding J, et al., 2009, Scar and Contracture:

Ethics approval and consent to participate Biological Principles. Hand Clin, 25(4):511–28.
https://doi.org/10.1016/j.hcl.2009.06.007
This study was approved by the Human Subjects 11. van Vlimmeren MA, Driessen-Mol A, van Den Broek M,
Ethics Sub-committee of The Hong Kong Polytechnic et al., 2010, Controlling matrix formation and cross-linking
University and Joint Chinese University of Hong Kong- by hypoxia in cardiovascular tissue engineering. J Appl
New Territories East Cluster Clinical Research Ethics
Committee. Written informed consent was obtained from Physiol (Bethesda, Md. 1985), 109(5):1483.
the participant before data collection. https://doi.org/10.1152/japplphysiol.00571.2010
12. Teekakirikul P, Eminaga S, Toka O, et al., 2010, Cardiac
Consent for publication Fibrosis in Mice with Hypertrophic Cardiomyopathy is

The patient provided written informed consent to publish Mediated by Non-myocyte Proliferation and Requires Tgf-
the pictures and her personal data. [Beta]. J Clin Investig, 120(10):3520–9.

132 International Journal of Bioprinting (2021)–Volume 7, Issue 1